BUY Dr. Lal Path Labs — Rupak De, 19 Aug 2026

byRupak De, LKP SecuritiesHorizon: 1–3 months19 Aug 2026via ET Now (Live)

Entry₹1,880.5Inferred

Target₹2,195

Stop lossNot given

CMP₹1,903.3Just now

Active+1.21%+15.33%upside left 2 mo left

Follow Rupak De for new calls(29% target hit, 35 closed calls)Get alerts Watch LALPATHLAB for new buy/sell callsGet alerts See 3 other Short-term calls on LALPATHLAB See 22 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 1:15 pm IST

12 supporting1 neutral1 opposing

Supports the BUY call (12)

1 advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·7 Sept · yesterday

Dr. Lal Ventures Private Limited, a wholly-owned subsidiary, has completed the subscription of a 30% stake in Neuome Technologies Private Limited. Neuome now becomes an associate of the company.

BSE · Company Update·27 Aug · 2w ago

Shri Bajrang Alliance Annual Report: Profit Up, Capacity Expansion Approved

NewsGoogle News·17 Aug · 3w ago

2 other SEBI-registered advisors have active short-term BUY calls on this stock

Advisor consensus · same horizon·30 Jul · 1mo ago

Neutral / worth noting (1)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·8 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Dr. Lal Path Labs Ltd. — Rupak De, LKP Securities

AI Assessment